Accelerate Diagnostics Price to Book Ratio 2010-2024 | AXDX
Historical price to book ratio values for Accelerate Diagnostics (AXDX) over the last 10 years. The current price to book ratio for Accelerate Diagnostics as of February 18, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Accelerate Diagnostics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-14 | 1.18 | 0.00 | |
| 2024-09-30 | 1.71 | $-1.95 | -0.88 |
| 2024-06-30 | 1.17 | $-1.47 | -0.79 |
| 2024-03-31 | 0.99 | $-1.18 | -0.84 |
| 2023-12-31 | 3.92 | $-1.37 | -2.87 |
| 2023-09-30 | 5.75 | $-2.42 | -2.38 |
| 2023-06-30 | 8.10 | $-2.69 | -3.01 |
| 2023-03-31 | 7.00 | $-3.89 | -1.80 |
| 2022-12-31 | 7.06 | $-2.28 | -3.09 |
| 2022-09-30 | 15.20 | $-1.03 | -14.80 |
| 2022-06-30 | 9.93 | $-7.77 | -1.28 |
| 2022-03-31 | 14.40 | $-8.16 | -1.77 |
| 2021-12-31 | 52.20 | $-5.18 | -10.07 |
| 2021-09-30 | 58.30 | $-6.12 | -9.52 |
| 2021-06-30 | 80.60 | $-11.34 | -7.11 |
| 2021-03-31 | 83.20 | $-11.14 | -7.47 |
| 2020-12-31 | 75.80 | $-10.90 | -6.95 |
| 2020-09-30 | 106.60 | $-8.71 | -12.24 |
| 2020-06-30 | 151.60 | $-6.58 | -23.05 |
| 2020-03-31 | 83.30 | $-4.17 | -19.97 |
| 2019-12-31 | 169.00 | $-1.35 | -125.30 |
| 2019-09-30 | 185.70 | $1.87 | 99.28 |
| 2019-06-30 | 228.80 | $4.77 | 47.96 |
| 2019-03-31 | 210.20 | $7.89 | 26.64 |
| 2018-12-31 | 115.00 | $10.58 | 10.87 |
| 2018-09-30 | 229.50 | $14.28 | 16.07 |
| 2018-06-30 | 223.00 | $17.54 | 12.71 |
| 2018-03-31 | 228.50 | $19.74 | 11.58 |
| 2017-12-31 | 262.00 | $21.32 | 12.29 |
| 2017-09-30 | 224.50 | $23.45 | 9.57 |
| 2017-06-30 | 273.50 | $25.69 | 10.65 |
| 2017-03-31 | 242.00 | $13.29 | 18.21 |
| 2016-12-31 | 207.50 | $15.11 | 13.74 |
| 2016-09-30 | 272.60 | $17.74 | 15.37 |
| 2016-06-30 | 143.90 | $20.51 | 7.02 |
| 2016-03-31 | 143.70 | $23.37 | 6.15 |
| 2015-12-31 | 214.90 | $25.98 | 8.27 |
| 2015-09-30 | 161.80 | $8.98 | 18.01 |
| 2015-06-30 | 258.10 | $11.04 | 23.38 |
| 2015-03-31 | 225.00 | $13.17 | 17.08 |
| 2014-12-31 | 191.90 | $14.78 | 12.98 |
| 2014-09-30 | 214.80 | $16.21 | 13.25 |
| 2014-06-30 | 260.00 | $17.65 | 14.73 |
| 2014-03-31 | 218.10 | $9.26 | 23.55 |
| 2013-12-31 | 122.00 | $9.97 | 12.24 |
| 2013-09-30 | 134.10 | $10.85 | 12.36 |
| 2013-06-30 | 81.20 | $7.09 | 11.46 |
| 2013-03-31 | 72.70 | $7.75 | 9.38 |
| 2012-12-31 | 40.30 | 0.00 | |
| 2012-10-31 | 36.00 | $5.31 | 6.79 |
| 2012-09-30 | 33.30 | 0.00 | |
| 2012-07-31 | 32.70 | 0.00 | |
| 2012-06-30 | 26.90 | 0.00 | |
| 2012-04-30 | 27.30 | $3.62 | 7.54 |
| 2012-03-31 | 10.50 | 0.00 | |
| 2012-01-31 | 12.80 | $4.04 | 3.17 |
| 2011-10-31 | 28.70 | $4.20 | 6.84 |
| 2011-07-31 | 38.90 | 0.00 | |
| 2011-04-30 | 38.60 | $4.50 | 8.58 |
| 2011-01-31 | 13.00 | $4.61 | 2.82 |
| 2010-10-31 | 11.00 | $4.63 | 2.37 |
| 2010-07-31 | 8.70 | 0.00 | |
| 2010-04-30 | 8.30 | $2.89 | 2.87 |
| 2010-01-31 | 6.80 | $3.05 | 2.23 |
| 2009-10-31 | 12.80 | $3.41 | 3.75 |
| 2009-07-31 | 27.00 | 0.00 | |
| 2009-04-30 | 19.80 | $3.89 | 5.08 |
| 2009-01-31 | 22.00 | $4.07 | 5.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.030B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $212.123B | 97.31 |
| Thermo Fisher Scientific (TMO) | United States | $203.433B | 24.33 |
| Edwards Lifesciences (EW) | United States | $44.937B | 29.08 |
| Alcon (ALC) | Switzerland | $44.417B | 29.72 |
| IDEXX Laboratories (IDXX) | United States | $36.400B | 41.66 |
| DexCom (DXCM) | United States | $34.790B | 53.98 |
| IQVIA Holdings (IQV) | United States | $34.065B | 18.87 |
| Mettler-Toledo (MTD) | United States | $26.604B | 30.90 |
| Waters (WAT) | United States | $21.953B | 31.15 |
| STERIS (STE) | Ireland | $21.550B | 24.65 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.044B | 0.00 |
| Hologic (HOLX) | United States | $14.190B | 15.31 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.755B | 14.12 |
| Globus Medical (GMED) | United States | $11.429B | 28.94 |
| Sysmex ADR (SSMXY) | Japan | $11.267B | 35.33 |
| Penumbra (PEN) | United States | $10.311B | 101.00 |
| Masimo (MASI) | United States | $9.707B | 46.97 |
| Glaukos (GKOS) | United States | $8.447B | 0.00 |
| Teleflex (TFX) | United States | $7.776B | 12.40 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.679B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.528B | 0.00 |
| Veracyte (VCYT) | United States | $3.186B | 95.61 |
| Nihon Kohden (NHNKY) | Japan | $2.705B | 14.78 |
| LivaNova (LIVN) | United Kingdom | $2.589B | 14.95 |
| TransMedics (TMDX) | United States | $2.422B | 76.79 |
| Elekta AB (EKTAY) | Sweden | $2.392B | 21.50 |
| Tandem Diabetes Care (TNDM) | United States | $2.198B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.866B | 9.75 |
| Alphatec Holdings (ATEC) | United States | $1.523B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.291B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 83.50 |
| RxSight (RXST) | United States | $1.201B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.935B | 0.00 |
| AxoGen (AXGN) | United States | $0.798B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.792B | 17.31 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.762B | 12.94 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.711B | 0.00 |
| IRadimed (IRMD) | United States | $0.700B | 36.82 |
| SiBone (SIBN) | United States | $0.687B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.628B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.521B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.505B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.460B | 24.23 |
| AngioDynamics (ANGO) | United States | $0.418B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.416B | 22.51 |
| NeuroPace (NPCE) | United States | $0.367B | 0.00 |
| CVRx (CVRX) | United States | $0.366B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.287B | 0.00 |
| Inogen (INGN) | United States | $0.253B | 0.00 |
| Accuray (ARAY) | United States | $0.229B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.132B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.127B | 0.00 |
| LENSAR (LNSR) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 13.77 |
| Vicarious Surgical (RBOT) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 30.14 |
| Microbot Medical (MBOT) | United States | $0.057B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |